Who to call at Matinas Biopharma Holdings, Inc., and when
Fundz watches for the moments Matinas Biopharma Holdings, Inc. starts buying, and tells you who to reach.
- An alert the day Matinas Biopharma Holdings, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Matinas Biopharma Holdings, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Matinas Biopharma Holdings, Inc.. With Fundz connected, it knows.
Matinas Biopharma Holdings, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.matinasbiopharma.comLeadership shakeup: 4 executive changes at Matinas BioPharma in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Matinas BioPharma's Chief Financial Officer, Keith Kucinski, notified the company on November 18, 2025 of his intent to resign effective January 17, 2026, to pursue other opportunities. The filing states the resignation was not due to any disagreement over operations, policies, or practices, but it creates a finance leadership transition the company must fill.
Key Takeaways
CFO Keith Kucinski will leave Matinas BioPharma effective January 17, 2026, roughly two months after notifying the company on November 18, 2025.
The company states the resignation was not the result of any disagreement on operations, policies, or practices, which reduces the likelihood of an underlying governance dispute.
2 more takeaways
Related Filings (9)
9 more filings from Matinas Biopharma Holdings, Inc. in the last 90 days
Filing Overview
What This Means
Matinas Biopharma Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.